8-K Announcements
6Material company update
May 18, 2026·SEC
Material company update
May 14, 2026·SEC
Material company update
May 1, 2026·SEC
Celcuity Inc.(CELC)Earnings, Financials & Key Ratios
CELC•NASDAQ
Price updated Jun 19, 2026
AboutCelcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.Show more
- Revenue$0
- EBITDA-$172M-52.1%
- Net Income-$177M-58.4%
- EPS (Diluted)-3.78-33.6%
- ROE-163.8%-87.1%
CELC Key Insights
Celcuity Inc. (CELC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Profits declining 79.6% over 5 years
- ✗Weak Piotroski F-Score: 3/9
- ✗Shares diluted 33.2% in last year
- ✗Trading more than 30% below 52-week high
- ✗Expensive at 45.9x book value
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CELC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CELC Price & Volume
Celcuity Inc. (CELC) stock price & volume — 10-year historical chart
Loading chart...
CELC Growth Metrics
Celcuity Inc. (CELC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-51.68%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-28.38%
Return on Capital
10 Years-46.03%
5 Years-48.26%
3 Years-50.16%
Last Year-54.16%
CELC Recent Earnings
Celcuity Inc. (CELC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)
Q2 2026Latest
May 14, 2026Metric
Actual
Est
EPS
$0.97+6.7%
$1.04
Rev
—
$3M
Q2 2026
Mar 25, 2026Metric
Actual
Est
EPS
$0.97+8.5%
$1.06
Rev
—
$1M
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.92+9.8%
$1.02
Rev
—
—
Q3 2025
Aug 14, 2025Metric
Actual
Est
EPS
$1.04-15.6%
$0.90
Rev
—
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 14, 2026 | $0.97vs $1.04+6.7% | —vs $3M |
| Q2 2026 | Mar 25, 2026 | $0.97vs $1.06+8.5% | —vs $1M |
| Q4 2025 | Nov 12, 2025 | $0.92vs $1.02+9.8% | — |
| Q3 2025 | Aug 14, 2025 | $1.04vs $0.90-15.6% | — |
Based on last 12 quarters of dataView full earnings history →
CELC Peer Comparison
Celcuity Inc. (CELC) competitors in Oncology Therapeutics Developers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 RVMD | 34.65B | 162.99 | -27.39 | -83.22% | 0.10 | |||
 KYMR | 7.38B | 90.43 | -24.51 | -16.72% | -6.12% | -25.02% | 0.05 | |
 TNGX | 3.25B | 27.97 | -32.15 | 48.29% | -188.15% | -41.54% | 0.10 | |
 PMVP | 60.26M | 1.13 | -0.76 | -68.98% | 0.01 | |||
 ACLX | 6.73B | 115.07 | -28.27 | -79.35% | -10.27% | -55.42% | 0.24 | |
 NUVL | 9.08B | 123.43 | -21.10 | -42.78% | ||||
 AGEN | 124.93M | 3.00 | -882.35 | 10.37% | 52.16% | |||
 MGNX | 262.52M | 4.13 | -3.50 | 0.78% | -44.79% | -147.8% | 1.92 |
Compare CELC vs Peers
Celcuity Inc. (CELC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CELC Income Statement
Celcuity Inc. (CELC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue Growth % | - | - | - | - | - | - | - | - | - | - |
Cost of Goods Sold | 104.7K | 223.04K | 0 | 0 | 0 | 0 | 0 | 0 | 167K | 47K |
COGS % of Revenue | - | - | - | - | - | - | - | - | - | - |
Gross Profit | -104.7K▲ 0% | -223.04K▼ 113.0% | 0▲ 100.0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | -167K▲ 0% | -47K▲ 0% |
Gross Margin % | - | - | - | - | - | - | - | - | - | - |
Gross Profit Growth % | -43.31% | -113.02% | 100% | - | - | - | - | - | - | - |
Operating Expenses | 5.95M | 7.93M | 7.81M | 9.56M | 28.36M | 39.39M | 66.23M | 113.27M | 172.19M | 186.52M |
OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
Selling, General & Admin | 972.52K | 1.61M | 1.78M | 2.13M | 2.6M | 4.38M | 5.64M | 9.06M | 27.2M | 40.73M |
SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - |
Research & Development | 4.98M | 6.33M | 6.27M | 7.68M | 25.76M | 35.29M | 60.59M | 104.2M | 145M | 145.83M |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 0 | 0 | -247.14K | -256.8K | 0 | -278.84K | 0 | 0 | 0 | 0 |
Operating Income | -5.95M▲ 0% | -7.93M▼ 33.3% | -7.81M▲ 1.6% | -9.56M▼ 22.4% | -28.36M▼ 196.7% | -39.39M▼ 38.9% | -66.23M▼ 68.1% | -113.27M▼ 71.0% | -172.19M▼ 52.0% | -186.57M▲ 0% |
Operating Margin % | - | - | - | - | - | - | - | - | - | - |
Operating Income Growth % | -78.85% | -33.25% | 1.6% | -22.43% | -196.73% | -38.92% | -68.14% | -71.02% | -52.02% | - |
EBITDA | -5.85M | -7.71M | -7.47M | -9.17M | -28.05M | -39.18M | -66.09M | -113.14M | -172.03M | -186.39M |
EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
EBITDA Growth % | -79.65% | -31.83% | 3.15% | -22.83% | -205.9% | -39.67% | -68.68% | -71.19% | -52.05% | -47.03% |
D&A (Non-Cash Add-back) | 104.7K | 223.04K | 339K | 385.59K | 303.24K | 210.92K | 142.77K | 129.95K | 167K | 177K |
EBIT | -5.95M | -7.48M | -7.81M | -9.56M | -28.34M | -39.39M | -58.45M | -101.5M | -159.89M | -172.84M |
Net Interest Income | -298.79K | 448.72K | 445.94K | 81.99K | -1.25M | -978.95K | 2.45M | 1.49M | -4.85M | -19.09M |
Interest Income | 152.88K | 448.83K | 446.1K | 82.11K | 13.26K | 1.13M | 7.78M | 11.77M | 12.3M | 13.73M |
Interest Expense | 451.66K | 111 | 159 | 120 | 1.26M | 2.11M | 5.33M | 10.28M | 17.15M | 32.82M |
Other Income/Expense | -298.79K | 451.72K | 445.94K | 81.99K | -1.25M | -978.95K | 2.45M | 1.49M | -4.85M | -6.32M |
Pretax Income | -6.25M▲ 0% | -7.48M▼ 19.7% | -7.36M▲ 1.6% | -9.47M▼ 28.7% | -29.61M▼ 212.5% | -40.37M▼ 36.4% | -63.78M▼ 58.0% | -111.78M▼ 75.3% | -177.04M▼ 58.4% | -192.89M▲ 0% |
Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
Income Tax | 48.17K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | -0.77% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -6.25M▲ 0% | -7.48M▼ 19.7% | -7.36M▲ 1.6% | -9.47M▼ 28.7% | -29.61M▼ 212.5% | -40.37M▼ 36.4% | -63.78M▼ 58.0% | -111.78M▼ 75.3% | -177.04M▼ 58.4% | -192.89M▲ 0% |
Net Margin % | - | - | - | - | - | - | - | - | - | - |
Net Income Growth % | -88.85% | -19.66% | 1.62% | -28.74% | -212.48% | -36.36% | -57.99% | -75.26% | -58.39% | -51.68% |
Net Income (Continuing) | -6.25M | -7.48M | -7.36M | -9.47M | -29.61M | -40.37M | -63.78M | -111.78M | -177.04M | -192.89M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.84▲ 0% | -0.74▲ 11.9% | -0.69▲ 6.8% | -0.89▼ 29.0% | -2.28▼ 156.2% | -2.68▼ 17.5% | -2.69▼ 0.4% | -2.83▼ 5.2% | -3.78▼ 33.6% | -3.54▲ 0% |
EPS Growth % | -71.43% | 11.9% | 6.76% | -28.99% | -156.18% | -17.54% | -0.37% | -5.2% | -33.57% | -28.38% |
EPS (Basic) | -0.84 | -0.74 | -0.69 | -0.89 | -2.28 | -2.68 | -2.69 | -2.83 | -3.78 | - |
Diluted Shares Outstanding | 7.46M | 10.12M | 10.23M | 10.27M | 13.38M | 15.42M | 23.68M | 39.45M | 52.54M | 54.46M |
Basic Shares Outstanding | 7.46M | 10.12M | 10.23M | 10.27M | 13.38M | 15.42M | 23.68M | 39.45M | 52.54M | 54.46M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
CELC Balance Sheet
Celcuity Inc. (CELC) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 24.48M | 25.22M | 19.25M | 12.17M | 85.35M | 175.16M | 190.59M | 244.57M | 465.66M | 408.93M |
Cash & Short-Term Investments | 24.2M | 24.9M | 18.76M | 11.66M | 84.29M | 168.59M | 180.58M | 235.1M | 441.5M | 145.19M |
Cash Only | 2.64M | 15.94M | 18.74M | 11.64M | 84.29M | 24.57M | 30.66M | 22.51M | 165.7M | 145.19M |
Short-Term Investments | 21.56M | 8.95M | 22.01K | 22.01K | 0 | 144.02M | 149.92M | 212.59M | 275.79M | 0 |
Accounts Receivable | 0 | 0 | 0 | 0 | 298.76K | 203.66K | 805.88K | 1.6M | 0 | 0 |
Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
Other Current Assets | 50K | 28.74K | 218.74K | 190K | 22.14K | 22.01K | 281.36K | 841.33K | 24.16M | 263.74M |
Total Non-Current Assets | 7.49M | 813.61K | 1.03M | 789.79K | 554.35K | 539.75K | 628.8K | 552.02K | 899K | 1.24M |
Property, Plant & Equipment | 280.06K | 813.61K | 1.03M | 789.79K | 554.35K | 506.56K | 628.8K | 552.02K | 550K | 632K |
Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 7.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 33.2K | 0 | 0 | 349K | 603K |
Total Assets | 31.97M▲ 0% | 26.03M▼ 18.6% | 20.28M▼ 22.1% | 12.96M▼ 36.1% | 85.91M▲ 563.0% | 175.7M▲ 104.5% | 191.22M▲ 8.8% | 245.12M▲ 28.2% | 466.56M▲ 90.3% | 410.16M▲ 0% |
Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x |
Asset Growth % | 427.81% | -18.57% | -22.09% | -36.11% | 563.02% | 104.52% | 8.83% | 28.19% | 90.34% | 215.47% |
Total Current Liabilities | 578.05K | 662.33K | 911.33K | 1.19M | 2.51M | 6.88M | 14.19M | 31.72M | 44.15M | 33.21M |
Accounts Payable | 71.91K | 119.81K | 142.77K | 217.38K | 1.51M | 2.63M | 5.08M | 9.37M | 6.41M | 10.45M |
Days Payables Outstanding | 250.69 | 196.07 | - | - | - | - | - | - | 14K | 76.57K |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 194.2K | 0 | 0 | 54K | 13K |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 54.51K | 63.88K | 0 | 0 | 472.93K | 3.09M | 7.11M | 0 | 37.69M | 22.74M |
Current Ratio | 42.36x | 38.07x | 21.12x | 10.26x | 34.06x | 25.45x | 13.43x | 7.71x | 10.55x | 12.31x |
Quick Ratio | 42.36x | 38.07x | 21.12x | 10.26x | 34.06x | 25.45x | 13.43x | 7.71x | 10.55x | 12.31x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
Total Non-Current Liabilities | 0 | 19.88K | 71.9K | 69.16K | 14.69M | 35.04M | 37.26M | 97.78M | 321.85M | 323.43M |
Long-Term Debt | 0 | 0 | 0 | 0 | 14.63M | 34.98M | 37.04M | 97.73M | 195.32M | 195.57M |
Capital Lease Obligations | 0 | 19.88K | 71.9K | 69.16K | 64.22K | 61K | 225.92K | 53.97K | 0 | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 126.53M | 127.86M |
Total Liabilities | 578.05K | 682.21K | 983.23K | 1.25M | 17.2M | 41.93M | 51.45M | 129.5M | 366M | 356.64M |
Total Debt | 0 | 25.61K | 256.14K | 262.49K | 14.89M | 35.24M | 37.45M | 97.95M | 195.38M | 195.58M |
Net Debt | -2.64M | -15.92M | -18.48M | -11.38M | -69.4M | 10.67M | 6.78M | 75.44M | 29.68M | 50.39M |
Debt / Equity | - | 0.00x | 0.01x | 0.02x | 0.22x | 0.26x | 0.27x | 0.85x | 1.94x | 3.65x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -1.05x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.27x |
Interest Coverage | -13.18x | -67393.73x | -49089.94x | -79634.70x | -22.45x | -18.70x | -10.97x | -9.87x | -9.32x | -5.27x |
Total Equity | 31.39M▲ 0% | 25.35M▼ 19.2% | 19.3M▼ 23.9% | 11.7M▼ 39.4% | 68.71M▲ 487.2% | 133.77M▲ 94.7% | 139.77M▲ 4.5% | 115.62M▼ 17.3% | 100.56M▼ 13.0% | 53.52M▲ 0% |
Equity Growth % | 459.4% | -19.25% | -23.87% | -39.36% | 487.16% | 94.69% | 4.48% | -17.28% | -13.03% | -148.03% |
Book Value per Share | 4.21 | 2.50 | 1.89 | 1.14 | 5.13 | 8.68 | 5.90 | 2.93 | 1.91 | 0.98 |
Total Shareholders' Equity | 31.39M | 25.35M | 19.3M | 11.7M | 68.71M | 133.77M | 139.77M | 115.62M | 100.56M | 53.52M |
Common Stock | 10.09K | 10.19K | 10.25K | 10.3K | 14.92K | 21.67K | 25.51K | 37.14K | 48K | 48K |
Retained Earnings | -2.01M | -9.49M | -16.85M | -26.32M | -55.93M | -96.3M | -160.08M | -271.86M | -448.9M | -501.74M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -260.12K | -480.9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CELC Cash Flow Statement
Celcuity Inc. (CELC) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -4.95M | -6.08M | -6M | -7.15M | -20.31M | -36.01M | -53.81M | -83.47M | -153.28M | -172.49M |
Operating CF Margin % | - | - | - | - | - | - | - | - | - | - |
Operating CF Growth % | -71.31% | -22.8% | 1.28% | -19.12% | -184.25% | -77.28% | -49.44% | -55.11% | -83.64% | -303.05% |
Net Income | -6.25M | -7.48M | -7.36M | -9.47M | -29.61M | -40.37M | -63.78M | -111.78M | -177.04M | -192.89M |
Depreciation & Amortization | 104.7K | 223.04K | 339K | 385.59K | 303.24K | 210.92K | 142.77K | 129.95K | 167K | 177K |
Stock-Based Compensation | 874.39K | 1.17M | 1.04M | 1.76M | 2.61M | 4.64M | 4.9M | 6.99M | 21.38M | 9.48M |
Deferred Taxes | 0 | -92.32K | 0 | -2.48M | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 426.57K | 89.32K | 42.91K | 2.48M | 5.56M | 704.66K | 1.06M | 2.84M | 4.86M | 20.48M |
Working Capital Changes | -101.91K | 15.89K | -62.24K | 179.02K | 819.81K | -1.19M | 3.86M | 18.35M | -2.65M | -9.75M |
Change in Receivables | 0 | 0 | -190K | 0 | -108.76K | 95.1K | 0 | 0 | 0 | 0 |
Change in Inventory | 0 | 0 | 190K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -262.51K | 25.43K | 45.62K | 52.97K | 1.31M | 1.08M | 2.43M | 4.32M | -3.04M | 427K |
Cash from Investing | -28.98M | 19.09M | 8.53M | -89.37K | -81.4K | -144.03M | -5.01M | -63.07M | -64.08M | -53.83M |
Capital Expenditures | -239.85K | -629.61K | -380.2K | -89.37K | -81.9K | -158.77K | -97.64K | -249.88K | -249K | -474K |
CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
Acquisitions | 0 | 4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -28.74M | 4K | 8.91K | 0 | 500 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | 30.71M | 236.7K | 259.31K | 137.97K | 93.04M | 120.33M | 64.91M | 138.39M | 360.55M | 355.03M |
Debt Issued (Net) | 7.49M | -3.32K | -5.73K | -5.77K | 14.34M | 19.5M | -2.45K | 59.23M | 222.75M | 222.75M |
Equity Issued (Net) | 24.11M | 0 | 0 | 182.69K | 78.55M | 100.5M | 14.43M | 63.61M | 137.85M | 117.25M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | -55.14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -894.57K | 240.02K | 265.04K | -38.96K | 148.02K | 324.12K | 50.48M | 15.55M | -46K | 15.03M |
Net Change in Cash | -3.22M▲ 0% | 13.25M▲ 512.1% | 2.79M▼ 78.9% | -7.1M▼ 354.3% | 72.65M▲ 1123.6% | -59.71M▼ 182.2% | 6.09M▲ 110.2% | -8.15M▼ 233.8% | 143.19M▲ 1857.4% | 128.71M▲ 0% |
Free Cash Flow | -5.19M▲ 0% | -6.71M▼ 29.3% | -6.38M▲ 4.9% | -7.24M▼ 13.4% | -20.39M▼ 181.9% | -36.17M▼ 77.3% | -53.91M▼ 49.1% | -83.72M▼ 55.3% | -153.53M▼ 83.4% | -172.93M▲ 0% |
FCF Margin % | - | - | - | - | - | - | - | - | - | - |
FCF Growth % | -77.11% | -29.26% | 4.88% | -13.42% | -181.88% | -77.34% | -49.06% | -55.29% | -83.39% | -68.76% |
FCF per Share | -0.70 | -0.66 | -0.62 | -0.70 | -1.52 | -2.35 | -2.28 | -2.12 | -2.92 | -3.18 |
FCF Conversion (FCF/Net Income) | 0.79x | 0.81x | 0.82x | 0.75x | 0.69x | 0.89x | 0.84x | 0.75x | 0.87x | 0.90x |
Interest Paid | 0 | 0 | 0 | 0 | 694.53K | 1.26M | 0 | 0 | 0 | 2.42M |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CELC Key Ratios
Celcuity Inc. (CELC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -33.79% | -26.37% | -32.97% | -61.12% | -73.63% | -39.88% | -46.63% | -87.54% | -163.8% | -244.61% |
Return on Invested Capital (ROIC) | -31.32% | -31.16% | -114.23% | -1251.29% | - | -41.1% | -34.14% | -50.32% | -80.39% | -80.57% |
Debt / Equity | - | 0.00x | 0.01x | 0.02x | 0.22x | 0.26x | 0.27x | 0.85x | 1.94x | 3.65x |
Interest Coverage | -13.18x | -67393.73x | -49089.94x | -79634.70x | -22.45x | -18.70x | -10.97x | -9.87x | -9.32x | -5.27x |
FCF Conversion | 0.79x | 0.81x | 0.82x | 0.75x | 0.69x | 0.89x | 0.84x | 0.75x | 0.87x | 0.90x |
Related:CELC Dividend History·CELC Revenue History·CELC Price History·CELC P/E History·CELC Financial Ratios·CELC Institutional Holders
CELC SEC Filings & Documents
Celcuity Inc. (CELC) SEC filings — annual & quarterly reports (10-K, 10-Q)
CELC Frequently Asked Questions
Celcuity Inc. (CELC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Celcuity Inc. (CELC) grew revenue by 0.0% over the past year. Growth has been modest.
Celcuity Inc. (CELC) reported a net loss of $192.9M for fiscal year 2025.
Dividend & Returns
Celcuity Inc. (CELC) has a return on equity (ROE) of -163.8%. Negative ROE indicates the company is unprofitable.
Celcuity Inc. (CELC) had negative free cash flow of $172.9M in fiscal year 2025, likely due to heavy capital investments.